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Present study was designed to evaluate in Renoprotective activity of Pioglitazone on Ischemia/reperfusion (I/R) induced renal 
damage in diabetic rats. Ischemia/reperfusion injury, which is commonly seen in the field of renal surgery or transplantation in 
diabetic condition, is a major cause of acute renal failure. Type 2 Diabetes was induced in rats by a single intraperitoneal (i.p) 
injection of Streptozotocin (65 mg/kg, STZ) in overnight fasting rats followed by the i.p administration of Nicotinamide (110 
mg/kg, NIC) after 15 minutes. After right nephrectomy, Piogltazone (10 mg/kg/day, p.o) was administered for 15 days. On the 
16th day, ischemia was induced in contra lateral kidney for 45 min, followed by reperfusion for 24 hr. Renal function marker 
and oxidative parameter were estimated at the end of 24 hr reperfusion.  At the end of experimental period the level of 
malondialdehyde formation/ lipid peroxidation (LPO) in kidney tissue and serum marker Creatinine, Urea and Uric acids were 
significantly increased. Whereas, the activity of biomarkers of oxidative stress such as reduced glutathione (GSH), catalase 
(CAT) and superoxide dismutase (SOD) were found to be decreased significantly compared to control rats. Pioglitazone 
improved the renal dysfunction and oxidative stress after renal ischemia/reperfusion injury in diabetic rats. In conclusion, 
Pioglitazone shows potent may improve renal function marker and oxidative stress in kidney in I/R induced renal damage in 
type 2 diabetic rats. 
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Introduction 
Ischemic injury to brain, heart, and kidney is 
associated with high morbidity and mortality. 
Improving the ability of these organs to tolerate 
ischemic injury would have important implications 
implications. Ischemic insults are often recurrent in 
diabetic patients. In the setting of loss of renal blood 
flow autoregulation that characterizes the post-
ischemic kidney [1], Renal ischemia/reperfusion (I/R) 
injury is a major cause of acute renal failure (ARF) 
[2], which is faced in many clinical situations such as 
kidney transplantation, partial nephrectomy, renal 
artery, angioplasty, aortic aneurysm surgery, and 
elective urological operations. In these conditions, 
I/R injury initiates a complex and interrelated 
sequence of events, resulting in injury to and the 
eventual death of renal cells [3, 4]. Several factors 
have been implicated in the pathophysiological 
changes occurring while renal I/R injury including 
vascular or microvascular injury, endothelial 
dysfunction, accelerated cell necrosis, granulocyte 
activation, and modulation of nitric oxide/angiotensin 
II axis [5, 6].  
The rennin-angiotensin system plays a pivotal 
role in regulation of blood pressure. Renin acts on 
angiotensinogen to form angiotensin I, which is 
converted to angiotensin II with the help of 
angiotensin-converting enzyme (ACE) [7]. 
Angiotensin II is an important mediator in kidney 
injury. Accumulating evidence suggests that 
angiotensin II stimulates intracellular formation of 
reactive oxygen species (ROS) such as the 
superoxide anion and hydrogen peroxide that leads 
to kidney damage [8]. 
Recently, a protective effect of Pioglitazone 
against oxidative stress in liver and kidney of 
diabetic rabbits [9] has been reported. Pioglitazone 
(PIO) hydrochloride is a widely used drug in the 
treatment of insulin resistance diabetes. PIO 
showed dose dependant beneficial effects in many 
of the pathological conditions including reduction in 
blood glucose, lowering blood pressure and 
restoring endothelial functions in animals [10]. 
Pioglitazone lowers blood pressure and restores 
blunted endothelium-dependent vasodilatation in 
fructose-fed rats [11], insulin-resistant rheus monkey 
[12], SHR [13] and sucrosefed SHR [14]. 
The present study, we investigated the 
protective effect of Pioglitazone on renal I/R injury in 
diabetic rats and other word effect of Pioglitazone 
on renal marker and oxidative stress of kidney 
tissues in I/R induced renal damage in diabetic rats. 
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Materials and Methods 
Drugs and Chemicals 
Pioglitazone hydrochloride was obtained as a 
gift sample from Alembic Pharmaceuticals Pvt.  Ltd., 
Baroda, India. STZ and NIC were obtained from 
SIGMA, St. Louis, MO, USA. All other chemicals 
and reagents used in the study were of analytical 
grade.  
Experimental Animals 
All experiments and protocols described in 
present study were approved by the Institutional 
Animal Ethics Committee (IAEC) of Dharmaj Degree 
Pharmacy College, Anand. Sprague Dawley rats 
(210 ± 15 g) were housed in-group of 3 animals per 
cage and maintained under standardized laboratory 
conditions (12- h light/dark cycle, 24°C) and 
provided free access to palleted CHAKKAN diet 
(Nav Maharashtra Oil Mills Pvt., Pune) and purified 
drinking water ad libitium. The animal experiment 
was approved by Animal Ethical Committee of the 
Institute (1163/a/08/CPCSEA). 
Experimental Induction of Type 2 Diabetes in 
Rats  
Type 2 Diabetes was induced in rats by a 
single intraperitoneal (i.p) injection of Streptozotocin 
(65 mg/kg, STZ) in overnight fasting rats followed by 
the i.p administration of Nicotinamide (110 mg/kg, 
NIC) after 15 minutes. STZ was dissolved in citrate 
buffer (pH 4.5) and NIC was dissolved in normal 
saline. After 7 days following STZ and NIC 
administration, blood was collected from retro-orbital 
puncture and serum samples were analyzed for 
blood glucose [15].  Animals showing fasting blood 
glucose higher than 250 mg/dL were considered as 
diabetic and used for the further study.  
Experimental Protocol 
The rats were divided into three groups each 
consisting of six animals: 
Group 1:Animals served as sham-operated 
(underwent all surgical procedures without ischemia 
reperfusion).   
Group 2: After right nephrectomy on day 1, 
vehicle (0.5 % sodium CMC) was administered for 
15 days; on day 16, ischemia was produced in the 
left kidney for 45 min, followed by reperfusion of 24 
hr (I/R control). 
Group 3: After right nephrectomy on day 1, 
Pioglitazone (10 mg/kg/day, p.o.) was administered 
for 15 days; on day 16, ischemia was produced in 




The progress of the experiment 
Day 1 Unilateral right nephrectomy 
Day 15 Treatment 
Day 16 45 minutes ischemia (left kidney) 
Day 17 24 hr reperfusion 
Right nephrectomy was performed through a 
right flank incision (2 cm) under general anesthesia, 
ketamine (100 mg/kg, i.p.). After right nephrectomy, 
several treatments were given as mentioned 
previously for 15 days. On day 16, ischemia was 
produced in the left kidney by performing a left flank 
incision and dissecting the left renal pedicle to 
expose the renal vessels. Non traumatic vascular 
clamps were used to stop blood flow (in artery and 
vein) for 45 min. Reperfusion was established by 
removing the clamp after 45 min ischemia. The 
abdominal wall (muscular layer and skin) was 
closed with 4.0 mononylon suture. At the end of 
reperfusion period (after 24 hr), blood samples were 
collected and used for the estimation of renal 
function (BUN and creatinine). The abdomen was 
opened, and the kidneys were harvested for the 
biomarkers of oxidative stress. 
 
 
Characterization of Type 2 Diabetes Model 
Type 2 diabetes was confirmed by measuring 
fasting serum glucose using standard diagnostic kit 
(SPAN diagnostics Pvt., India) and the degree of 
uncontrolled diabetic state was confirmed by 
measuring HbA1c  (Ion Exchange Resin method). 
After seven day, diabetes was confirmed by 
measuring glucose and HbA1c as mentioned above. 
Estimation of kidney function marker  
Blood was collected from the rats by retro-
orbital puncture at the time of sacrify and was 
allowed to clot for 10 minutes at room temperature. 
Clots were centrifuged at 2500 rpm for 10 minutes 
to separate the serum. Serum creatinine and urea 
levels were measured by assay kits (SPAN 
Diagnostics Pvt. India) and Serum Uric acid levels 
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Preparation of Tissue Homogenate 
After sacrificing the animals, their kidneys 
were quickly removed, perfused immediately with 
ice cold hypertonic saline solution, weighed and 
homogenized in chilled Tris buffer (10 mM, pH 7.4) 
at a concentration of 10% (w/v). The homogenates 
were centrifuged at 10,000×g at 0oC for 20 min 
using Remi C-24 high speed cooling centrifuge. The 
clear supernatant was used for the assay of 
following antioxidant parameters. The levels of Lipid 
peroxidation (LPO) formation and the activities of 
endogenous antioxidant enzymes such as catalase 
(CAT), reduced glutathione (GSH) and superoxide 
dismutase (SOD) were estimated by the method of 
Slater and Sawyer [16] Hugo Aebi as given by Hugo 




All of the data are expressed as mean ± SEM. 
Statistical significance between more than two 
groups was tested using one-way ANOVA followed 
by the Bonferroni multiple comparisons test or 
unpaired two-tailed student’s t-test as appropriate 
using a computer-based fitting program (Prism, 
Graphpad 5). Differences were considered to be 
statistically significant when p < 0.05. 
Results 
Characterization of Type 2 Diabetes 
Single intraperitoneal (i.p) injection of 
Streptozotocin (65mg/kg) followed by i.p 
administration of Nicotinamide (110 mg/kg) to rats 
produced severe hyperglycemia and increased 
HbA1c in 70 to 80 % the animals (Table 1).
 
Table 1. Effect of Streptozotocin (65mg/kg/day, p.o) and Nicotinamide (110 mg/kg/day, p.o) on serum glucose and HbA1c changes level in 
rats. 
 
Groups Glucose HbA1c 
CON 101.8 ± 6.799 5.455 ± 0.3729 
STZ + NIC 332.8 ± 9.167*** 9.900 ± 0.6323*** 
Values are expressed as mean ± SEM for six animals in the group. ***P<0.001 
considered statistically significant as compared to respective Control group. 
Effect of PIO on kidney function marker 
The six rats which underwent renal I/R 
exhibited a significant increase in the serum 
concentrations of creatinine (P < 0.001), urea (P < 
0.001), and uric acid (P < 0.001) compared with the 
sham control animals, suggesting a significant 
degree of glomerular dysfunction mediated by renal 
I/R. In I/R+PIO treated diabetic rats, serum 
creatinine, urea and uric acid levels were 
significantly (p< 0.05, n = 6) higher as compared to 
I/R control group alone (Fig.1). 
Figure 1.Effect of Pioglitazone (10 mg/kg/day, p.o) on serum Creatinine (A), Urea (B), and Uric acid (C) in the diabetic rats exposed 
to renal ischemia/reperfusion (I/R) injury. 
 

















Values are expressed as mean ± SEM for six animals in the group. * P<0.05, **P<0.01, ***P<0.001 considered statistically significant 
as compared to respective Sham group. 
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Effect of PIO on antioxidant activity 
Renal I/R group of diabetic rats showed 
significantly decreased enzymatic activity of 
superoxide dismutage (P<0.001), catalase 
(P<0.001), and reduced glutathione (P<0.001) when 
compared with the sham control rats. These 
declining trends were significantly (P<0.05, P<0.01, 
P<0.05, respectively Sham control Group) 
decreased in the group treated with PIO compared 
with those in the I/R-only group (Fig. 2). Renal I/R 
produced a significant (P<0.001) increase in MDA 
levels in comparison with the sham operation in the 
rats. Treatment with PIO before renal I/R was 
associated with a significantly (P<0.05) lower MDA 
level than that in the rats that underwent only renal 
I/R (Fig. 2). 
 
Figure 2.Effect of Pioglitazone (10 mg/kg/day, p.o) on Superoxide dismutase (A), Catalase(B), Reduced glutathione (C) and lipid 




































Values are expressed as mean ± SEM for six animals in the group. * P<0.05, **P<0.01, ***P<0.001 considered statistically significant 
as compared to respective Sham group. 
 
Discussion 
The present study was under taken with the 
objective of exploring evaluate Pioglitazone on renal 
marker in I/R induced renal damage in diabetic rats. 
The transient discontinuation of renal blood supply 
is encountered in many clinical situations such as 
kidney transplantation, partial nephrectomy, renal 
artery angioplasty, aortic aneurysm surgery, and 
elective urological operations [3, 4]. This transient 
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discontinuation causes renal I/R injury which results 
in decreased glomerular filtration and renal blood 
flow and increased urine output characterized by 
natriuresis and impaired concentrating ability. Much 
of this tubular and glomerular dysfunction has been 
postulated to occur during the reperfusion period 
following anoxia, and generation of ROS has been 
postulated as one of the major factors contributing 
to this reperfusion injury. In renal I/R injury, ROS are 
capable of reacting with lipids leading to lipid 
peroxidation of biological membranes, which in turn 
impacts enzymatic processes, such as ion pump 
activity, inhibiting transcription and repair of DNA. If 
lipid peroxidation remains unchecked, it will 
ultimately result in cell death [20, 21]. 
In our study, animals subjected to renal I/R 
demonstrated an increase in the renal MDA and at 
tenuated antioxidant enzymes pool. Lipid 
peroxidation and antioxidant enzymes are important 
indexes of oxidant injury [22]. Demonstration of lipid 
peroxidation as indexes for oxidative damage may 
help us better understand the effects of ROS on the 
cellular components[23]. Renal I/R-induced 
oxidative stress was associated with impaired 
kidney function, leading to a marked increase in 
serum creatinine, urea, and uric acid levels. 
Pretreatment with Pioglitazone prevented 
renal I/R-induced lipid peroxidation and protected 
the kidneys from severe attenuation of antioxidant 
enzymes activity in rats exposed to the renal I/R. 
Furthermore, the impaired kidney function was 
significantly improved by Pioglitazone. The 
mechanism of the protective effect of Pioglitazone 
on renal I/R injury can be explained by its 
antioxidant activity [9].  
The rennin-angiotensin system plays a pivotal 
role in regulation of blood pressure. Renin acts on 
angiotensinogen to form angiotensin-I, which is 
converted to angiotensin-II with the help of 
angiotensin-converting enzyme.6 Accumulating 
evidence suggests that angiotensin-II stimulates 
intracellular formation of ROS such as superoxide 
anion and hydrogen peroxide that leads to kidney 
damage [8]. Generation of ROS has been 
postulated as one of the major factors contributing 
to this reperfusion injury. Oxidative stress can result 
from increased ROS production, and/or from 
decreased ROS scavenging capability. The ROS 
attach to the polyunsaturated fatty acids in the 
membrane lipids and result in peroxidation, which 
may lead to disorganization of cell structure and 
function. After reperfusion and reoxygenation, the 
imbalance between restoration of oxygen supply 
and mitochondrial respiratory function results in 
massive generation of superoxide anion in 
mitochondria [22, 23]. Under these conditions, the 
defensive system, which is known as antioxidant or 
antioxidant enzymes, cannot prevent the escape of 
ROS, especially in mitochondria, and their effects on 
other intracellular sites. This cascade of events is 
known as reperfusion injury [23]. In this study, renal 
I/R increased oxidative stress products including 
tissue MDA and depleted the antioxidant enzymes 
pool, as is evident from the declined activity of 
superoxide dismutage, catalase, and reduced 
glutathione. It can be speculated that pretreatment 
with Pioglitazone prevented renal I/R-induced lipid 
peroxidation and protected the kidneys from severe 
increasing of ROS products and depletion of 
superoxide dismutage and reduced glutathione in 
rats exposed to the renal I/R. 
Conclusions 
It is important to inhibit oxidative stress to 
prevent renal I/R injury in diabetic condition. Our 
data support a role for Pioglitazone in attenuation of 
kidney damage after I/R injury of the kidneys in an 
animal model, in part at least by antioxidant or free 
radical scavanging activity.  
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